SinoMab BioScience Limited (3681.HK)

HKD 1.03

(-1.9%)

Total Debt Summary of SinoMab BioScience Limited

  • SinoMab BioScience Limited's latest annual total debt in 2023 was 450.8 Million CNY , up 26.21% from previous year.
  • SinoMab BioScience Limited's latest quarterly total debt in 2024 Q2 was 423.77 Million CNY , down 0.0% from previous quarter.
  • SinoMab BioScience Limited reported annual total debt of 357.18 Million CNY in 2022, up 29.67% from previous year.
  • SinoMab BioScience Limited reported annual total debt of 275.45 Million CNY in 2021, up 181.55% from previous year.
  • SinoMab BioScience Limited reported quarterly total debt of 450.8 Million CNY for 2023 FY, up 26.21% from previous quarter.
  • SinoMab BioScience Limited reported quarterly total debt of 450.8 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of SinoMab BioScience Limited (2023 - 2017)

Historical Annual Total Debt of SinoMab BioScience Limited (2023 - 2017)

Year Total Debt Total Debt Growth
2023 450.8 Million CNY 26.21%
2022 357.18 Million CNY 29.67%
2021 275.45 Million CNY 181.55%
2020 97.83 Million CNY 82.49%
2019 53.61 Million CNY -11.04%
2018 60.26 Million CNY -71.57%
2017 211.98 Million CNY 0.0%

Peer Total Debt Comparison of SinoMab BioScience Limited

Name Total Debt Total Debt Difference
Uni-Bio Science Group Limited 52.86 Million HKD -752.721%
CK Life Sciences Int'l., (Holdings) Inc. 5.93 Billion HKD 92.399%